Form 8-K - Current report:
SEC Accession No. 0000912057-02-028104
Filing Date
2002-07-22
Accepted
2002-07-22 16:49:23
Documents
4
Period of Report
2002-07-22
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K a2084986z8-k.htm 8-K 14953
3 EXHIBIT 20.1 a2084986zex-20_1.htm EX-20.1 13746
4 EX20-11950IMAGE001.JPG ex20-11950image001.jpg GRAPHIC 2702
5 EX20-11950IMAGE002.GIF ex20-11950image002.gif GRAPHIC 1104
  Complete submission text file 0000912057-02-028104.txt   34518
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13341 | Film No.: 02707918
SIC: 2836 Biological Products, (No Diagnostic Substances)